Oncology and Hematology
Episodes 81-96 of 105
Joshua E. Reuss, MD
Jessica S. Donington, MD, MSCR
Ticiana Leal, MD
Jacob Sands, MD
Joshua E. Reuss, MD
Jessica S. Donington, MD, MSCR
- MinuteCE®
Case Study: Sequencing Therapy in ES-SCLC in Special Patient Populations
1.50 program creditsTiciana Leal, MD
Jacob Sands, MD
Jessica S. Donington, MD, MSCR
Joshua E. Reuss, MD
- MinuteCE®
Panel Discussion: Patient Selection, Emerging Studies and Strategies in ES-SCLC
1.50 program creditsTiciana Leal, MD
Jacob Sands, MD
- MinuteCE®
Case Study: Treatment Sequencing in Platinum-Resistant Relapse ES-SCLC
1.50 program creditsTiciana Leal, MD
Jacob Sands, MD
Ticiana Leal, MD
Jacob Sands, MD
Joshua E. Reuss, MD
Jessica S. Donington, MD, MSCR
Paul Paik, MD
D. Ross Camidge, MD, PhD
Keith Kerr, BSc, MB ChB
- MinuteCE®
What Is the Pharmacist’s Role in Managing mHSPC Doublet and Triplet Regimens?
1.00 program creditLisa Holle, PharmD, BCOP, FHOPA, FISOPP
Alicia K. Morgans, MD, MPH
Kelvin A. Moses, MD, PhD, FACS
- MinuteCE®
Expert Panel: Selecting Treatment in mHSPC: Which Treatment for Which Patient?
1.00 program creditKelvin A. Moses, MD, PhD, FACS
Alicia K. Morgans, MD, MPH
Kelvin A. Moses, MD, PhD, FACS
Alicia K. Morgans, MD, MPH
Kelvin A. Moses, MD, PhD, FACS
